Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population – A prospective, multi-center, observational study (BLAST 1)-Reference-Cited by-同舟云学术

Therapeutic drug monitoring of meropenem and piperacillin-tazobactam in the Singapore critically ill population – A prospective, multi-center, observational study (BLAST 1)

Published:2022-04 Issue: Volume:68 Page:107-113
ISSN:0883-9441
Container-title:Journal of Critical Care
language:en
Short-container-title:Journal of Critical Care

Author:

Chua Nathalie Grace,Loo Liwen,Hee Daryl Kim Hor,Lim Tze Peng,Ng Tat Ming,Hoo Grace Si Ru,Soong Jie Lin,Ong Jasmine Chiat Ling,Tang Sarah Si Lin,Zhou Yvonne Peijun,Lee Winnie,Lee Lawrence Soon-U,Cove Matthew,Ling Li Min,Kwa Andrea Layhoon

Funder

National Healthcare Group

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine

Reference42 articles.

1. International study of the prevalence and outcomes of infection in intensive care units;Vincent;JAMA.,2009

2. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data;Van Boeckel;Lancet Infect Dis,2014

3. Prevalence of healthcare-associated infections and antimicrobial use among adult inpatients in Singapore acute-care hospitals: results from the first National Point Prevalence Survey;Cai;Clin Infect Dis,2017

4. Therapeutic drug monitoring of the beta-lactam antibiotics: what is the evidence and which patients should we be using it for?;Huttner;J Antimicrob Chemother,2015

5. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions;Roberts;Lancet Infect Dis,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Extended Meropenem Regimen and Achievement of Aggressive PK/PD in Patients Receiving Continuous Renal Replacement Therapy for Septic AKI;Antibiotics;2024-08-11

2. Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review;Frontiers in Antibiotics;2024-06-17

3. Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis;Critical Care;2024-04-16

4. Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: a systematic review and meta-analysis of randomized clinical trials and observational studies;Scientific Reports;2024-04-02

5. Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP;Antibiotics;2024-03-25